Array Digital's 15min chart triggers KDJ Golden Cross, Bullish Marubozu Pattern
ByAinvest
Tuesday, Aug 26, 2025 2:46 pm ET2min read
AD--
The KDJ Golden Cross, generated by the KDJ indicator, occurs when the K line crosses above the D line. This is typically interpreted as a bullish signal indicating a potential shift in the stock's momentum towards the upside [1]. The Bullish Marubozu, a candlestick pattern, is characterized by a long body with no shadows above or below, suggesting that the stock is being driven by strong buying pressure [2].
These signals align with a broader trend of narrowing Bollinger Bands and KDJ Death Cross formations observed in several other stocks [1, 2, 3]. While technical indicators provide valuable insights into potential stock price movements, it is crucial for investors to consider these signals in conjunction with fundamental analysis and broader market conditions.
In addition to the technical indicators, several analyst ratings and price targets have been updated recently, offering valuable insights into the potential performance of various stocks. As of July 7, 2025, several notable companies have seen updates to their analyst ratings and price targets, reflecting the evolving opinions of financial experts [1].
Positive Outlook:
- Alnylam Pharma (ALNY) received a "Buy" rating from Jefferies with a price target of $384.00 [1].
- Chime Financial (CHYM) was initiated with an "Overweight" rating by multiple firms, including Morgan Stanley and Barclays, with targets ranging from $39.00 to $40.00 [1].
- CryoPort (CYRX) was rated "Buy" by BTIG Research with a price target of $10.00 [1].
- Datadog (DDOG) had its price target raised from $150.00 to $175.00 by Bank of America, reiterating a "Buy" rating [1].
- Energy Transfer (ET) was initiated with a "Buy" rating by TD Cowen with a price target of $22.00 [1].
- Grab (GRAB) was rated "Buy" by Jefferies with a price target of $5.70, indicating a 20.94% upside [1].
- Home Depot (HD) was rated "Buy" by TD Cowen with a price target of $470.00 [1].
- Intuit (INTU) was rated "Buy" by Morgan Stanley with a price target of $900.00 [1].
- JPMorgan Chase & Co. (JPM) had a $298.00 target set by Evercore ISI with an "Outperform" rating [1].
- Kinder Morgan (KMI) was initiated with a "Buy" rating by TD Cowen [1].
- Lam Research (LRCX) had its "Buy" rating reiterated by Citigroup [1].
- MACOM Technology Solutions (MTSI) had its target raised from $136.00 to $154.00 by Truist Financial, maintaining a "Buy" rating [1].
- Monopar Therapeutics (MNPR) was initiated with an "Overweight" rating by Cantor Fitzgerald and a target of $74.00 [1].
- Norwegian Cruise Line (NCLH) received a "Buy" rating from Jefferies with a price target of $29.00 [1].
- Oracle (ORCL) received a "Buy" rating from UBS with a $250.00 target [1].
- Oportun Financial (OPRT) was rated "Buy" at B. Riley Financial with an $11.00 price target [1].
- Ovintiv (OVV) was rated "Buy" at Barclays Capital with a price target of $55.00 [1].
- Phibro Animal Health (PAHC) was upgraded at JPMorgan Chase from Neutral to Overweight, with the price target raised from $25.00 to $35.00 [1].
- Progressive (PGR) was downgraded by Morgan Stanley from Overweight to Equal Weight, with a price target of $290.00 [1].
- Pulse Biosciences (PLSE) was initiated by Oppenheimer with an "Outperform" rating and a $22.00 price target [1].
- PTC (PTC) had its Overweight rating reiterated by KeyCorp Bank [1].
- Rockwell Automation (ROK) was initiated by CICC Research with a "Buy" rating and a price target of $320.00 [1].
Investors should closely monitor the technical indicators and analyst ratings to make informed decisions about their investments. While the bullish signals for AD are promising, it is essential to consider the broader market context and other fundamental indicators before making any investment decisions.
References:
[1] https://www.ainvest.com/news/lz-15min-chart-triggers-kdj-golden-cross-bullish-marubozu-2508-37/
[2] https://en.coinotag.com/bitcoin-bull-flag-pattern-suggests-possible-breakout-toward-130k-if-120k-resistance-holds/
[3] https://www.tradingview.com/news/tradingview:da51d5b4314b5:0-penumbra-director-arani-sells-12-000-shares/
ALNY--
BAC--
BCS--
BINI--
The 15-minute chart for Array Digital has recently exhibited a bullish trend, as indicated by the KDJ Golden Cross and the appearance of a bullish Marubozu at 14:30 on August 26, 2025. This suggests that the momentum of the stock price is shifting towards the upside, potentially leading to further increases. As buyers currently hold control of the market, a continuation of the bullish momentum is likely.
On August 26, 2025, at 14:30, the 15-minute chart for Array Digital (AD) exhibited a significant technical indicator: the KDJ Golden Cross, accompanied by a Bullish Marubozu pattern. This combination of signals suggests a shift in the momentum of the stock price towards an upward trajectory, indicating potential further gains. The strong buying pressure evident in the Bullish Marubozu pattern indicates that buyers have taken control of the market, and it is likely that this bullish momentum will continue.The KDJ Golden Cross, generated by the KDJ indicator, occurs when the K line crosses above the D line. This is typically interpreted as a bullish signal indicating a potential shift in the stock's momentum towards the upside [1]. The Bullish Marubozu, a candlestick pattern, is characterized by a long body with no shadows above or below, suggesting that the stock is being driven by strong buying pressure [2].
These signals align with a broader trend of narrowing Bollinger Bands and KDJ Death Cross formations observed in several other stocks [1, 2, 3]. While technical indicators provide valuable insights into potential stock price movements, it is crucial for investors to consider these signals in conjunction with fundamental analysis and broader market conditions.
In addition to the technical indicators, several analyst ratings and price targets have been updated recently, offering valuable insights into the potential performance of various stocks. As of July 7, 2025, several notable companies have seen updates to their analyst ratings and price targets, reflecting the evolving opinions of financial experts [1].
Positive Outlook:
- Alnylam Pharma (ALNY) received a "Buy" rating from Jefferies with a price target of $384.00 [1].
- Chime Financial (CHYM) was initiated with an "Overweight" rating by multiple firms, including Morgan Stanley and Barclays, with targets ranging from $39.00 to $40.00 [1].
- CryoPort (CYRX) was rated "Buy" by BTIG Research with a price target of $10.00 [1].
- Datadog (DDOG) had its price target raised from $150.00 to $175.00 by Bank of America, reiterating a "Buy" rating [1].
- Energy Transfer (ET) was initiated with a "Buy" rating by TD Cowen with a price target of $22.00 [1].
- Grab (GRAB) was rated "Buy" by Jefferies with a price target of $5.70, indicating a 20.94% upside [1].
- Home Depot (HD) was rated "Buy" by TD Cowen with a price target of $470.00 [1].
- Intuit (INTU) was rated "Buy" by Morgan Stanley with a price target of $900.00 [1].
- JPMorgan Chase & Co. (JPM) had a $298.00 target set by Evercore ISI with an "Outperform" rating [1].
- Kinder Morgan (KMI) was initiated with a "Buy" rating by TD Cowen [1].
- Lam Research (LRCX) had its "Buy" rating reiterated by Citigroup [1].
- MACOM Technology Solutions (MTSI) had its target raised from $136.00 to $154.00 by Truist Financial, maintaining a "Buy" rating [1].
- Monopar Therapeutics (MNPR) was initiated with an "Overweight" rating by Cantor Fitzgerald and a target of $74.00 [1].
- Norwegian Cruise Line (NCLH) received a "Buy" rating from Jefferies with a price target of $29.00 [1].
- Oracle (ORCL) received a "Buy" rating from UBS with a $250.00 target [1].
- Oportun Financial (OPRT) was rated "Buy" at B. Riley Financial with an $11.00 price target [1].
- Ovintiv (OVV) was rated "Buy" at Barclays Capital with a price target of $55.00 [1].
- Phibro Animal Health (PAHC) was upgraded at JPMorgan Chase from Neutral to Overweight, with the price target raised from $25.00 to $35.00 [1].
- Progressive (PGR) was downgraded by Morgan Stanley from Overweight to Equal Weight, with a price target of $290.00 [1].
- Pulse Biosciences (PLSE) was initiated by Oppenheimer with an "Outperform" rating and a $22.00 price target [1].
- PTC (PTC) had its Overweight rating reiterated by KeyCorp Bank [1].
- Rockwell Automation (ROK) was initiated by CICC Research with a "Buy" rating and a price target of $320.00 [1].
Investors should closely monitor the technical indicators and analyst ratings to make informed decisions about their investments. While the bullish signals for AD are promising, it is essential to consider the broader market context and other fundamental indicators before making any investment decisions.
References:
[1] https://www.ainvest.com/news/lz-15min-chart-triggers-kdj-golden-cross-bullish-marubozu-2508-37/
[2] https://en.coinotag.com/bitcoin-bull-flag-pattern-suggests-possible-breakout-toward-130k-if-120k-resistance-holds/
[3] https://www.tradingview.com/news/tradingview:da51d5b4314b5:0-penumbra-director-arani-sells-12-000-shares/
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet